11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Meet the Veristat team at Booth #47, April 16th and 17th in Berlin.
The Science-First CRO™ and Consultancy Ready to Advance Your Revolutionary Therapy's Development, Approval, and Commercialization
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
For 30 years, Veristat has helped sponsors turn clinical complexity into clearer direction, stronger decisions, and submission confidence.
As a Science-First CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
The Science-First CRO.™
Schedule A Meeting
Veristat team member, Balma Gil, Senior Business Development Director, and Lorenzo Scalise, Business Development Manager, will be at the venue, ready to listen to your needs and share Veristat’s expertise. Discover what makes Veristat a distinguished name in the clinical research industry.
You can arrange a meeting by completing the form on the right side of this page.
Conference Details
Website: German Biotech Days
Schedule A Meeting
Meet with us at German Biotech Days 2024 by filling out the form below.
Event Topics:
8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...